Guardian Wealth Advisors (North Carolina)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Guardian Wealth Advisors (North Carolina)'s BMY Position: Q1 2026 in Review
Guardian Wealth Advisors (North Carolina) reduced its Bristol-Myers Squibb (BMY) stake by 5.5% in Q1 2026, selling an estimated $15.6K and leaving 4,589 shares worth $278K. The position accounts for 0.02% of the portfolio, ranked #293.
Guardian Wealth Advisors (North Carolina) first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $644K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Guardian Wealth Advisors (North Carolina) held 4,589 shares of Bristol-Myers Squibb worth $278K as of Q1 2026.
- Guardian Wealth Advisors (North Carolina) sold 268 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.6K.
- Bristol-Myers Squibb made up 0.02% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #293 holding.
- Guardian Wealth Advisors (North Carolina) first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
- Guardian Wealth Advisors (North Carolina)'s Bristol-Myers Squibb position peaked at $644K in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.